Butterfly Network Shares Rise 22% After FDA Clearance of Ultrasound System
2024年1月9日 - 2:53AM
Dow Jones News
By Chris Wack
Butterfly Network shares were up 22% to $1.23 after the company
received Food and Drug Administration clearance of its
next-generation handheld point-of-care ultrasound system, Butterfly
iQ3.
The stock has risen 36% in the last month, but is down 45% in
the past year.
The digital health company said the new device is its third
iteration of the world's first semiconductor-based single-probe,
whole-body ultrasound system.
Butterfly iQ3 features include a new ergonomic design and it
will deliver double the data processing speed for optimized image
resolution, sensitivity and penetration.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
January 08, 2024 12:38 ET (17:38 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Butterfly Network (NYSE:BFLY)
過去 株価チャート
から 5 2024 まで 6 2024
Butterfly Network (NYSE:BFLY)
過去 株価チャート
から 6 2023 まで 6 2024
